Hemolytic-uremic syndrome other diagnostic studies

Jump to navigation Jump to search

Hemolytic-uremic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemolytic-uremic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemolytic-uremic syndrome other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemolytic-uremic syndrome other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemolytic-uremic syndrome other diagnostic studies

CDC on Hemolytic-uremic syndrome other diagnostic studies

Hemolytic-uremic syndrome other diagnostic studies in the news

Blogs on Hemolytic-uremic syndrome other diagnostic studies

Directions to Hospitals Treating Hemolytic-uremic syndrome

Risk calculators and risk factors for Hemolytic-uremic syndrome other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [3]

Overview

Other diagnostic studies associated with HUS include complement protein levels and complement gene mutational analysis.

Other Diagnostic Studies

Other diagnostic studies associated with HUS include complement protein levels and complement gene mutational analysis.[1]

  • Complement factor C3 mutation
  • Complement factor C4 mutation
  • Complement factor B mutation
  • Complement factor H mutation
  • Complement factor H-related (CFHR) genes 1-3 mutations
  • Complement factor I mutation
  • Membrane cofactor protein (MCP) mutation
  • Thrombomodulin (THBD) mutation
  • Anti-Complement factor H antibody

References

  1. Loirat C, Frémeaux-Bacchi V (2011). "Atypical hemolytic uremic syndrome". Orphanet J Rare Dis. 6: 60. doi:10.1186/1750-1172-6-60. PMC 3198674. PMID 21902819.

Template:WH Template:WS